Targeted molecular cancer therapiescreated by breaking down cancer’s complexity
Mosaic Therapeutics is an oncology therapeutics company dedicated to resolving cancer’s complexity to power new treatments for patients, alone and in combination.
Built on over a decade of research from the Wellcome Sanger Institute, in collaboration with the Netherland’s Cancer Institute, Mosaic’s proprietary platform sits at the interface of computational and experimental medicine, driving the accelerated discovery of novel drugs and the precise identification of biomarkers to create the right drug, for the right patient.
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. Without these cookies, some parts of our site or the service being requested will be impossible to provide.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.